IndustryCompany release

Merck KGaA to acquire Rapid Micro Biosystems in $0.75-per-share cash tender offer

🇺🇸 Rapid Micro Biosystems, Inc. (RPID) · Mon 16 Nov 2026

Rapid Micro Biosystems, maker of the Growth Direct automated microbial QC system, has signed a definitive deal with Merck KGaA, with closing expected in December 2026.

Rapid Micro Biosystems signed a definitive agreement on 16 November 2026 to be acquired by Merck KGaA, Darmstadt, Germany. Merck KGaA will pay $0.75 per share in cash.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time

Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.

We'll email you a link to confirm your address, then take you to secure checkout (Stripe). Billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. Already a subscriber? Enter your email and the link will sign you in. See our terms and privacy policy.

Company's press release (SEC filing): Rapid Micro Biosystems, Inc. ↗

Article written by VigiEye from the official source (Rapid Micro Biosystems, Inc.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →